This was awesome. Something I’m still confused about is what exactly is it that PopVax does better - is it the machine learning feedback loop or the in vivo testing lots of things in mice or the combination of the two - what is the actual bottleneck?
Exactly! A 10-fold improvement is already a big deal in pharma R&D, and even that requires rigorous validation. Claiming 250x sounds more like a pitch for investors than a scientifically grounded statement. And for mRNA drugs, which are still under intense scrutiny for safety and long-term effects, this kind of hype could easily backfire.
Are they at least providing preclinical or clinical data to support this, or is it just theoretical modeling?
Really really good
This was an amazing interview- such great stuff here. Feeling inspired.
It does sound like a stretch! Are they backing it up with solid data, or is this just hype? Wait for Clinical Trials.
This was awesome. Something I’m still confused about is what exactly is it that PopVax does better - is it the machine learning feedback loop or the in vivo testing lots of things in mice or the combination of the two - what is the actual bottleneck?
Exactly! A 10-fold improvement is already a big deal in pharma R&D, and even that requires rigorous validation. Claiming 250x sounds more like a pitch for investors than a scientifically grounded statement. And for mRNA drugs, which are still under intense scrutiny for safety and long-term effects, this kind of hype could easily backfire.
Are they at least providing preclinical or clinical data to support this, or is it just theoretical modeling?